UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000003682
Receipt number R000004462
Scientific Title A Phase III randomized controlled clinical trial of CARBOPLATIN and PACLITAXEL(OR GEMCITABINE) alone or in combination with BEVACIZUMAB (NSC #704865, IND #7921) followed by BEVACIZUMAB and secondary cytoredutive surgery in platinum sensitive, recurrent ovarian, peritoneal primary and fallopian tube cancer.
Date of disclosure of the study information 2010/06/01
Last modified on 2024/02/15 15:07:38

No. Disposal Last modified on Item of update
1 Insert 2010/05/31 17:52:58
2 Update 2010/11/30 14:52:56 Institutions
3 Update 2010/11/30 15:09:32 Key inclusion criteria
Key inclusion criteria
4 Update 2010/11/30 17:21:32 Region
5 Update 2010/11/30 17:54:31 TEL
Co-sponsor
Co-sponsor
Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
6 Update 2011/12/21 14:41:17 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
Target sample size
7 Update 2011/12/21 14:42:27 Co-sponsor
Post marketing survey by drug manufacture etc., specified by Japanese law.
8 Update 2011/12/21 14:43:03 Last follow-up date
9 Update 2012/05/31 12:34:32 Key inclusion criteria
Key inclusion criteria
10 Update 2012/05/31 12:35:23 Institutions
11 Update 2012/05/31 12:36:34 Last follow-up date
12 Update 2012/12/03 16:29:09 Public title
Public title
13 Update 2012/12/04 14:14:37 Institutions
14 Update 2013/01/09 14:57:47 No. of arms
Interventions/Control_5
Interventions/Control_5
Interventions/Control_6
Interventions/Control_6
Interventions/Control_7
Interventions/Control_7
Interventions/Control_8
Interventions/Control_8
15 Update 2013/01/09 14:58:43 Institutions
16 Update 2013/01/09 14:59:26 Other related information
17 Update 2013/05/31 10:07:58 Division name
Division name
18 Update 2013/08/16 12:17:35 Institutions
19 Update 2013/12/10 09:52:32 TEL
Email
Address
Address
TEL
Email
20 Update 2015/06/01 10:22:16 Name of person sending information
Name of person sending information
21 Update 2015/11/06 15:40:01 Institutions
22 Update 2015/12/02 11:39:32 Randomization unit
Target sample size
23 Update 2015/12/28 09:39:29 UMIN ID1
24 Update 2015/12/28 09:54:22 Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Co-sponsor
Co-sponsor
25 Update 2015/12/28 13:31:14 Email
26 Update 2016/05/31 10:21:24 Name of primary person or sponsor
Organization
27 Update 2017/06/16 11:21:09 Name of person sending information
Name of person sending information
Division name
Division name
28 Update 2017/06/16 11:28:11 Recruitment status
Date of protocol fixation
Anticipated trial start date
Publication of results
29 Update 2018/08/24 10:20:14 Name of person sending information
Name of person sending information
30 Update 2019/05/23 10:24:35 Recruitment status
Date of IRB
Last follow-up date
31 Update 2024/02/15 15:07:38 UMIN ID2